These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2748937

  • 1. Misonidazole chemosensitization of EMT6 spheroids to melphalan.
    Horsman MR, Wood PJ, Brown JM.
    Radiother Oncol; 1989 May; 15(1):103-14. PubMed ID: 2748937
    [Abstract] [Full Text] [Related]

  • 2. Misonidazole hypoxic cytotoxicity and chemosensitization in two cell lines with different intracellular glutathione levels.
    DeGraff WG, Russo A, Friedman N, Mitchell JB.
    Eur J Cancer; 1990 Jan; 26(1):17-20. PubMed ID: 2138473
    [Abstract] [Full Text] [Related]

  • 3. Oxygen dependence for chemosensitization by misonidazole.
    Roizin-Towle L, Hall EJ, Pirro JP.
    Br J Cancer; 1986 Dec; 54(6):919-24. PubMed ID: 3801287
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of melphalan crosslink enhancement by misonidazole pretreatment.
    Taylor YC, Sawyer JM, Hsu B, Brown JM.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1603-7. PubMed ID: 6480448
    [Abstract] [Full Text] [Related]

  • 5. Hypoxic fraction and binding of misonidazole in EMT6/Ed multicellular tumor spheroids.
    Franko AJ.
    Radiat Res; 1985 Jul; 103(1):89-97. PubMed ID: 4070561
    [Abstract] [Full Text] [Related]

  • 6. Growth delay in small EMT6 spheroids induced by cytotoxic drugs and its modification by misonidazole pretreatment under hypoxic conditions.
    Twentyman PR.
    Br J Cancer; 1982 Apr; 45(4):565-70. PubMed ID: 7073947
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
    Horsman MR, Evans JW, Brown JM.
    Br J Cancer; 1984 Sep; 50(3):305-16. PubMed ID: 6466544
    [Abstract] [Full Text] [Related]

  • 8. Enhancing effect of pre-treatment of cells with misonidazole in hypoxia on their response to melphalan in air.
    Smith E, Stratford IJ, Adams GE.
    Br J Cancer; 1982 Jul; 46(1):117-26. PubMed ID: 7104191
    [Abstract] [Full Text] [Related]

  • 9. Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole.
    Roizin-Towle LA, Hall EJ.
    Br J Cancer; 1981 Aug; 44(2):201-7. PubMed ID: 6168277
    [Abstract] [Full Text] [Related]

  • 10. Interactions between misonidazole and hyperthermia in EMT6 spheroids.
    Morgan JE, Bleehen NM.
    Br J Cancer; 1981 Dec; 44(6):810-8. PubMed ID: 7326192
    [Abstract] [Full Text] [Related]

  • 11. Studies on the mechanism of chemosensitization by misonidazole in vitro.
    Taylor YC, Bump EA, Brown JM.
    Int J Radiat Oncol Biol Phys; 1982 Dec; 8(3-4):705-8. PubMed ID: 7107402
    [Abstract] [Full Text] [Related]

  • 12. Decreased hypoxic toxicity and binding of misonidazole by low glucose concentration.
    Ling LL, Streffer C, Sutherland R.
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1231-4. PubMed ID: 3744943
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
    McNally NJ, Hinchliffe M, de Ronde J.
    Br J Cancer; 1983 Aug; 48(2):271-8. PubMed ID: 6882665
    [Abstract] [Full Text] [Related]

  • 14. An investigation of the possibility of chemosensitization by clinically achievable concentrations of misonidazole.
    Twentyman PR, Workman P.
    Br J Cancer; 1983 Feb; 47(2):187-94. PubMed ID: 6824566
    [Abstract] [Full Text] [Related]

  • 15. Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids.
    Gross MW, Karbach U, Groebe K, Franko AJ, Mueller-Klieser W.
    Int J Cancer; 1995 May 16; 61(4):567-73. PubMed ID: 7759162
    [Abstract] [Full Text] [Related]

  • 16. Enhanced cytotoxicity of melphalan by prolonged exposure to nitroimidazoles: the role of endogenous thiols.
    Roizin-Towle L, Hall EJ, Flynn M, Biaglow JE, Varnes ME.
    Int J Radiat Oncol Biol Phys; 1982 May 16; 8(3-4):757-60. PubMed ID: 7107410
    [Abstract] [Full Text] [Related]

  • 17. Binding of misonidazole to V79 spheroids and fragments of Dunning rat prostatic and human colon carcinomas in vitro: diffusion of oxygen and reactive metabolites.
    Franko AJ, Koch CJ.
    Int J Radiat Oncol Biol Phys; 1984 Aug 16; 10(8):1333-6. PubMed ID: 6469756
    [Abstract] [Full Text] [Related]

  • 18. Time-dose relationships for simultaneous misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea exposures in vitro.
    Mulcahy RT, Dembs N.
    Cancer Res; 1983 Aug 16; 43(8):3539-43. PubMed ID: 6861127
    [Abstract] [Full Text] [Related]

  • 19. Chemosensitization: do thiols matter?
    Roizin-Towle L, Hall EJ, Costello T, Biaglow JE, Varnes ME.
    Int J Radiat Oncol Biol Phys; 1984 Sep 16; 10(9):1599-602. PubMed ID: 6480447
    [Abstract] [Full Text] [Related]

  • 20. The advantageous use of hypoxic tumour cells in cancer therapy: identical chemosensitization by metronidazole and misonidazole at moderately elevated temperatures.
    Urano M, Wong KH, Reynolds R, Begley J.
    Int J Hyperthermia; 1995 Sep 16; 11(3):379-88. PubMed ID: 7636324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.